Villalba-Lopez F, Saenz-Mateos LF, Sanchez-Lorencio MI, De La Orden-Garcia V, Alconchel-Gago F, Cascales-Campos PA, Garcia-Bernardo C, Noguera-Velasco JA, Baroja-Mazo A, Ramirez-Romero P. Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma. Sci Rep. 2023 Apr 6;13(1):5621. doi: 10.1038/s41598-023-32879-9. PubMed PMID: 37024609; PubMed Central PMCID: PMC10079651.

Journal: Scientific Reports
AÑO: 2023; IF: 4.6

37024609

Garcia-Carmona JA, Amores-Iniesta J, Soler-Usero J, Cerdan-Sanchez M, Navarro-Zaragoza J, Lopez-Lopez M, Soria-Torrecillas JJ, Ballesteros-Arenas A, Perez-Vicente JA, Almela P. Upregulation of Heat-Shock Protein (hsp)-27 in a Patient with Heterozygous SPG11 c.1951C>T and SYNJ1 c.2614G>T Mutations Causing Clinical Spastic Paraplegia. Genes (Basel). 2023 Jun 23;14(7):1320. doi: 10.3390/genes14071320. PubMed PMID: 37510225; PubMed Central PMCID: PMC10379220.

Journal:
AÑO: 2023; IF: 4.141

37510225

Jimenez-Coll V, El Kaaoui El Band J, Llorente S, Gonzalez-Lopez R, Fernandez-Gonzalez M, Martinez-Banaclocha H, Galian JA, Botella C, Moya-Quiles MR, Minguela A, Legaz I, Muro M. All That Glitters in cfDNA Analysis Is Not Gold or Its Utility Is Completely Established Due to Graft Damage: A Critical Review in the Field of Transplantation. Diagnostics (Basel). 2023 Jun 6;13(12):1982. doi: 10.3390/diagnostics13121982. PubMed PMID: 37370877; PubMed Central PMCID: PMC10297394.

Journal:
AÑO: 2023; IF: 3.992

37370877

Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Banaclocha HM, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia. Clin Transl Oncol. 2023 Jan 4. doi: 10.1007/s12094-022-03042-z. Online ahead of print. PubMed PMID: 36598635.

Journal: Clinical & Translational Oncology
AÑO: 2023; IF: 3.4

36598635

Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Martinez Banaclocha H, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia. Clin Transl Oncol. 2023 Jun 27. doi: 10.1007/s12094-023-03251-0. Online ahead of print. PubMed PMID: 37368200.

Journal: Clinical & Translational Oncology
AÑO: 2023; IF: 3.4

37368200